Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 373782
                    [Title] => Study compares two osteoporosis drugs
                    [Summary] => 

A retrospective study of over 33,000 postmenopausal women showed that among patients prescribed one of the two most popular osteoporosis treatments, those taking risedronate sodium were approximately half as likely to sustain a hip fracture as those taking alendronate in the first year of treatment. 


These results were published recently in the peer-reviewed journal Osteoporosis International.  


                    [DatePublished] => 2006-12-07 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

RISEDRONATE

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 373782
                    [Title] => Study compares two osteoporosis drugs
                    [Summary] => 

A retrospective study of over 33,000 postmenopausal women showed that among patients prescribed one of the two most popular osteoporosis treatments, those taking risedronate sodium were approximately half as likely to sustain a hip fracture as those taking alendronate in the first year of treatment. 


These results were published recently in the peer-reviewed journal Osteoporosis International.  


                    [DatePublished] => 2006-12-07 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Study compares two osteoporosis drugs

December 7, 2006 - 12:00am

A retrospective study of over 33,000 postmenopausal women showed that among patients prescribed one of the two most popular osteoporosis treatments, those taking risedronate sodium were approximately half as...

Science and Environment